Dr Li Yi-Heng
Cardiologist, National Cheng Kung University Hospital, Taiwan
Dr James L Januzzi
Cardiologist, Massachusetts General Hospital. Prof of Medicine, Harvard Medical School

NT-proBNP in Hospital & Ambulatory Settings: Evidence to Clinical Practice


  • Biomarkers play a useful role in the comprehensive management of patients with Heart Failure
  • NT-proBNP is used in Emergency Departments, ward and outpatient setting
  • In the era of ARNi, NT-proBNP is more useful than BNP for monitoring treatment

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy. [...]


CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi